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The genetic code is degenerate, meaning that more than
one codon can specify an amino acid. When a mutation
alters a codon but not the amino acid it encodes, we call it
a synonymousmutation and assume it hasno effect. Recent
evidence suggests that we may have to rethink the idea
that these changes are silent. The evidence comes from
comparisons of b- and g-actin, which are 98% identical at
the amino acid level but have strikingly different localiza-
tions and functions in cells. b-actinwas known tobe arginy-
lated at its N terminus, and a lack of this posttranslational
modification alters its localization, suggesting that it could
be at least partially responsible for the divergence in func-
tion between the two actins. When Zhang et al. looked
closely at g-actin, however, they found that it is also arginy-
lated but that this form of g-actin is rapidly degraded by the
proteasome. Why? The difference turns out to be due to
differences in codon usage in the first stretch of the two
genes. The codons used for g-actin are predicted to slow
the rate of translation of the protein, relative to those that
encode b-actin. This appears to allow time before the
protein folds for a normally internal lysine in the nascent
g-actin protein to be ubiquitinated, targeting it for degrada-
tion. Indeed, when the authors exchanged b-actin codons
with those used for g-actin while completely maintaining
the b-actin amino acid sequence, b-actin was destabilized.
In the converse experiment, g-actin that used b-actin
codons was stabilized. If protein function can be deter-
mined at the nucleotide level, we still have a lot to learn
about the complexity of the genetic code, and we may be
ignoring relevant synonymous changes.
Zhang et al. Science 329, 1534–1537. 10.1126/
science.1191701.
The Difference between No Protein and Some
Several mutations in the gene encoding presenilin-1 have
been reported in early-onset autosomal-dominant Alz-
heimer disease (AD). All of these mutations have so far
been missense or in-frame changes to the gene. A recent
paper reports a surprising allelic disorder with this early
onset form of AD: acne inversa. This chronic and painful
inflammatory skin disease mainly involves areas of skin
with apocrine glands, such as the armpits and groin area
and can cause extensive scarring. Presenilin is the catalytic
subunit of the g-secretase, which cleaves such proteins as
amyloid precursor protein and Notch. It works in complex1Department of Human Genetics, Emory University School of Medicine, Atlan
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families with acne inversa whowere examined in this study,
all had mutations in components of this protease. Affected
individuals from two families had frameshift mutations in
the gene encoding PEN2, whereas the other four families
appeared to exhibit digenic inheritance; each affected indi-
vidual carried frameshift or nonsense mutations in each of
twogenes, those encodingpresenilinandNCT.This suggests
that complete loss of function of part of this complex
causes an inflammatory disease of hair follicles and that
a missense change causes a neurodegenerative disorder.
This intriguing finding suggests that we have a lot more to
discover about the work of g-secretase. Furthermore, it sug-
gests that the multiple presenilin knockout animal models
might not capture the relevant disease process for AD.
Wang et al. Science Express. Published online October 7,
2010. 10.1126/science/1196284.
Too Many Qs, Not Enough Answers (But Getting
There)
Although polyglutamine (polyQ) is the common link to
several neurodegenerative diseases, there must be more to
the toxic mechanism than just the polyQ, because each
disease is distinct and involves different neurons. Data
suggest that the protein context in which the polyQ resides
is critical to the outcome, but whether and how the native
function of these proteins influences the disease pathogen-
esis is an open question. The gene that is involved in spino-
bulbar muscular atrophy (SBMA) encodes the androgen
receptor (AR), one of the few polyQ-associated proteins
that have a well understood function. This led Nedelsky
et al. to use a Drosophila model to zero in on the relevance
of specific steps inAR function topolyQ-mediatedneurode-
generation. Through the mutation of various domains of
AR, they demonstrate that normal functions of AR,
including translocation to the nucleus, DNA binding, and
interaction with other proteins, are required for polyQ
toxicity in their model. As a control in their experiments,
the authors used AR with a wild-type-length polyQ tract
and found that, unexpectedly, high levels of expression of
this construct caused neurodegeneration. Putting this
togetherwith their other results, they surmise thatneurode-
generation in SBMA may be at least partially the result of
enhancement of native functions or interactions of the AR.
Nedelsky et al. Neuron 67, 936–952. 10.1016/
j.neuron.2010.08.034.ta, GA 30322, USA
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Here’s to Homogeneity
Although the main way that we lump cancers into groups
is based on the tissue that is affected, there is clearly hetero-
geneity in these groups in terms of pathology and
outcomes. Splitting these groups into more homogeneous
subsets on the basis of pathology and, increasingly, the
mutational composition of the tumors is aimed at making
better predictions of outcome and developing more tar-
geted treatments for each subset. Recent work by Antoniou
et al. suggests that this splitting of groups could also
improve the power to detect genetic susceptibility alleles
for cancer. Their research was instigated by the finding
that few of the known breast cancer susceptibility alleles
modify risk of breast cancer in women with BRCA1 muta-
tions and thus do not contribute to the incomplete pene-
trance of the BRCA1 mutations. This led them to conduct
a genome-wide association study in BRCA1 mutation
carriers, comparing those who had invasive breast cancer
by age 40 with those who had not been diagnosed with
breast cancer. They identified a region of chromosome
19p13 that influences the risk of breast cancer, particularly
estrogen receptor negative disease, in women with BRCA1
mutations, and they went on to show that it is more
broadly associated with risk of estrogen receptor negative
breast cancer, a type of cancer that makes up less than
one-quarter of breast cancers in women of European
ancestry. As outlined in the accompanying News & Views
by Kraft and Haiman, failure to take into account tumor
subtype vastly reduces the power to detect an association
signal that is specific to one subtype, such as the one at
chromsome 19p13. Beyond the potential for additional578 The American Journal of Human Genetics 87, 577–579, Novembrisk information for carriers of BRCA1mutations, this locus
could lead to greater understanding of the development of
estrogen receptor negative breast cancer, which currently
has a worse prognosis than the more common estrogen
receptor positive disease.
Antoniou et al. Nature Genetics 42, 885–892. 10.1038/
ng.669.
Breathing Easier with Rett Syndrome
Breathing irregularities, including episodic apnea, are
a common feature of the neurological disorder Rett
syndrome and are recapitulated in Mecp2-deficient mice.
A recent study by Abdala et al. shows that apnea in the
mouse model is characterized by excessive excitatory
activity in expiratory cranial and spinal nerves. On the
basis of this fact, together with the fact that these mice
have deficits in GABA synaptic inhibition, the authors
decided to test whether augmenting GABA might improve
the breathing problems associated with Mecp2 deficiency.
Indeed, this treatment decreases the incidence of apnea in
heterozygous knockout female mice. The results are even
better when GABA reuptake inhibitors are given in combi-
nation with a serotonin agonist; the combination treat-
ment reduces the incidence of apnea to wild-type levels
and corrects the breathing irregularities. This work suggests
the possibility that drug treatment could be used to
moderate breathing irregularities in girls with Rett
syndrome because the underlying respiratory control
network is intact.
Abdala et al. PNAS 107, 18208–18213. 10.1073/
pnas.1012104107.This Month in Our Sister JournalsPhenotype to Genotype and Back Again?
More and more copy-number variations (CNV) in the
human genome are being named culprits in neurodevelop-
mental disorders, including the autism spectrum disorders
(ASDs). Sometimes, though, the use of a referring diagnosis
as the sole phenotypic feature of interest limits our under-
standing of the potential phenotypic consequences of
a CNV. To go beyond this one-dimensional view, Rosenfeld
et al. sorted twice through their large collection of samples
that were tested for CNV, using microarray-based compara-
tive genomic hybridization. The first time, they analyzed
only samples from individuals whowere referred for testing
for ASD, and they found a potentially causative abnor-
mality in 7.7% of samples overall. These included 41 auto-
somal regions that do not have a well described association
with ASD. The second time that they sorted through their
samples, they looked for individuals without an ASD
referral who had overlapping CNV with these 41 regions,
and they found that only 19% of themhad autistic features
or an ASD diagnosis. Together with the fact that some ofthese CNVs overlap with those previously identified in
patients with other neurodevelopmental disorders,
including schizophrenia andattentiondeficithyperactivity
disorder, this analysis could suggest that the CNVs are asso-
ciated with a range of neurodevelopmental phenotypes,
albeit a suggestion that needs to bemore clearly elucidated.
Because many of the CNVs in this study are inherited from
presumably normal parents, the authors presume that,
even with a contributing CNV, the inheritance of these
phenotypes may be more akin to a complex trait than we
might have hoped,making predictions of phenotype based
on the presence of one of these CNVs tenuous.
Rosenfeld et al. Genetics in Medicine. Published online
August 30, 2010. 10.1097/GIM.0b013e3181f0c5f3.
Go Ahead and Have Another Cup
Ah, coffee! Besides its aromatic appeal, epidemiological
studies suggest that it reduces the risk of Parkinson disease
and Alzheimer disease (AD). The question is: How? In
a recent paper in Genetics, Dostal et al. use C. elegans aser 12, 2010
a model system to figure out how coffee might be neuro-
protective. In their worm model, inducible expression of
human Ab42, a peptide that plays a key role in the develop-
ment of AD, leads to rapid paralysis. The paralysis is
rescued if the worms are grown in agar that contains
a coffee extract. Although full-octane coffee works better
in this assay than does decaf, the fact that pure caffeine
is not protective to the worms suggests that it isn’t the
major source of the protective effect. Coffee extracts confer
protection by inducing the skn-1 detoxification pathway,
an effect that can be blocked through knockdown or muta-The Americantion of skn-1. The functional equivalent of Skn-1 in
mammals is Nrf2, which is neuroprotective in a variety
of mammalian neurodegeneration models and believed
to be induced by coffee, thereby linking this pathway
back to the reduced risk of AD in coffee drinkers. Under-
standing this mechanistic link to the epidemiological
data means that the dietary modulation of this neuropro-
tective pathway can be further explored. So go ahead and
have that second cup; it might be good for you.
Dostal et al. Genetics. Published online August 30, 2010.
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